4.3 Article

Tissue-specific populations from amniotic fluid-derived mesenchymal stem cells manifest variant in vitro and in vivo properties

Related references

Note: Only part of the references are listed.
Article Cell & Tissue Engineering

MSCs derived from amniotic fluid and umbilical cord require different administration schemes and exert different curative effects on different tissues in rats with CLP-induced sepsis

Rui Chen et al.

Summary: The study showed that amniotic fluid-derived mesenchymal stem cells (AF-MSCs) and umbilical cord-derived mesenchymal stem cells (UC-MSCs) have different therapeutic effects in treating CLP-induced sepsis in rats, exerting varied effects on different tissues affected by sepsis.

STEM CELL RESEARCH & THERAPY (2021)

Article Biochemistry & Molecular Biology

Prophylactic Therapy with Human Amniotic Fluid Stem Cells Improves Long-Term Cognitive Impairment in Rat Neonatal Sepsis Survivors

Yushi Abe et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Neuroprotection of the hypoxic-ischemic mouse brain by human CD117+CD90+CD105+ amniotic fluid stem cells

Michelangelo Corcelli et al.

SCIENTIFIC REPORTS (2018)

Review Obstetrics & Gynecology

Amniotic Fluid Stem Cells: A New Era in Regenerative Medicine

Mala Srivastava et al.

JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA (2018)

Review Obstetrics & Gynecology

Human amniotic fluid: a source of stem cells for possible therapeutic use

Margaret Dziadosz et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)

Article Cell & Tissue Engineering

Molecular and Phenotypic Characterization of Human Amniotic Fluid-Derived Cells: A Morphological and Proteomic Approach

Caterina Pipino et al.

STEM CELLS AND DEVELOPMENT (2015)

Article Cell & Tissue Engineering

Immune Regulatory Properties of CD117pos Amniotic Fluid Stem Cells Vary According to Gestational Age

Mariano Di Trapani et al.

STEM CELLS AND DEVELOPMENT (2015)

Article Cell & Tissue Engineering

Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis

Francisca Alcayaga-Miranda et al.

STEM CELL RESEARCH & THERAPY (2015)

Article Physiology

Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes

Anna Krasnodembskaya et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2012)

Article Biotechnology & Applied Microbiology

Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach

Dafni Moschidou et al.

MOLECULAR THERAPY (2012)

Review Biochemistry & Molecular Biology

CD117+ amniotic fluid stem cells State of the art and future perspectives

Mara Cananzi et al.

ORGANOGENESIS (2012)

Article Cell Biology

In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells

Maria G. Roubelakis et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)

Article Critical Care Medicine

Mesenchymal Stem Cells Reduce Inflammation while Enhancing Bacterial Clearance and Improving Survival in Sepsis

Shirley H. J. Mei et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

Article Biochemical Research Methods

Variations of Protein Levels in Human Amniotic Fluid Stem Cells CD117/2 Over Passages 5-25

Wei-Qiang Chen et al.

JOURNAL OF PROTEOME RESEARCH (2009)

Article Biochemical Research Methods

Immunodesign of experimental sepsis by cecal ligation and puncture

Daniel Rittirsch et al.

NATURE PROTOCOLS (2009)

Article Biotechnology & Applied Microbiology

Isolation of amniotic stem cell lines with potential for therapy

Paolo De Coppi et al.

NATURE BIOTECHNOLOGY (2007)